About 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide
3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide (PubChem CID 158404603) has the molecular formula C52H44F6N12O4S2
and a molecular weight of 1079.13 g/mol. Its IUPAC name is 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide.
Analyze 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide?
The IUPAC name of 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide (CID 158404603) is 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide.
What is the SMILES notation for 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide?
The canonical SMILES for 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide is [H]/N=C(\N)c1cccc(-n2nc(C(F)(F)F)cc2CN2CCc3cc(-c4ccccc4S(N)(=O)=O)ccc32)c1.[H]/N=C(\N)c1cccc(-n2nc(C(F)(F)F)cc2Cn2ccc3cc(-c4ccccc4S(N)(=O)=O)ccc32)c1.
What is the InChIKey of 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide?
The InChIKey is GYNGTORYAZXANQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H23F3N6O2S.C26H21F3N6O2S/c2*27-26(28,29)24-14-20(35(33-24)19-5-3-4-18(13-19)25(30)31)15-34-11-10-17-12-16(8-9-22(17)34)21-6-1-2-7-23(21)38(32,36)37/h1-9,12-14H,10-11,15H2,(H3,30,31)(H2,32,36,37);1-14H,15H2,(H3,30,31)(H2,32,36,37).
What are the key properties of 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide?
3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide has a molecular weight of 1079.13 g/mol, XLogP of 8.54, 12 rotatable bonds, 6 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[5-[[5-(2-sulfamoylphenyl)-2,3-dihydroindol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide;3-[5-[[5-(2-sulfamoylphenyl)indol-1-yl]methyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenecarboximidamide is sourced from PubChem (CID 158404603), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).